Diagnostic test of rifampicin resistance in mycobacterium tuberculosis: A meta-analysis

Journal of Evidence-Based Medicine

Volumn 4, Issue 1, 2011, Pages 15-21

  Ma, Bin ^a   Qi, Guo qin ^a   Li, Hai ming ^a   Zhu, Bing dong ^a   Yang, Ke hu ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

Mycobacterium tuberculosis; Non radioactive mycobacterium culture system; SROC; Systematic review

Indexed keywords

RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BIOSIS; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EMBASE; HUMAN; MEDLINE; META ANALYSIS; MICROORGANISM DETECTION; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RADIOACTIVITY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

ANTIBIOTICS, ANTITUBERCULAR; DIAGNOSTIC TESTS, ROUTINE; DRUG RESISTANCE, BACTERIAL; HUMANS; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN;

EID: 79952097821     PISSN: 17565383     EISSN: 17565391     Source Type: Journal    
DOI: 10.1111/j.1756-5391.2011.01117.x     Document Type: Article

References (26)

1. Pablos-Méndez A, Raviglione MC, Laszlo A, Binkin N, Rieder HL, Bustreo F, et al Global surveillance for antituberculosis drug resistance:1994-1997. World Health Organization 2 International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med. 1998; 338(23): 1641-9.
2. Phthisiology Branch of Chinese Medical Association. The guideline of diagnosis and therapy in pulmonary tuberculosis. Chinese Journal of Tuberculosis and Respiratory Diseases 2002; 24(2): 70-4.
3. The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance: Anti-Tuberculosis drug resistance in the world. Report number 2 Volume. Geneva, 2004
4. Cohn DL, Bustreo F, Raviglione MC. Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease. Clin Infect Dis. 1997; 24(Suppl 1): S121-30.
5. He GJ. The importance of molecular biology for multi-drug resistant tuberculosis in new century. Chinese Journal of contagious disease 2001; 19(6): 325.
6. Blbum of prevenion and cure for tuberculosis in China. Disease Control Bureau of Ministry of Public Health, 2001: 8.
7. Liu YH, Jiang GL, Zhao LP, Fu YH. The fourth tuberculosis epidemiological random sampling survey in China-the analysis and assessment about the drug resistance of mycobacterium tuberculosis. Chinese Journal of Tuberculosis and Respiratory Diseases 2002; 25(4): 224-7.
8. Angeby KA, Klintz L, Hoffner SE. Rapid and inexpensive drug susceptibility testing of Mycobacterium tuberculosis with a nitrate reductase assay. J Clin Microbiol 2002 Feb; 40(2): 553-5.
9. Panaiotov S, Kantardjiev T. Nitrate reduetase assay for drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbio1 2002; 40(10): 388l-2.
10. Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part II. Active tuberculosis and drug resistance. Expert Rev Mol Diagn 2006; 6(3): 423-32.
11. Heifets LB, Cangelosi GA. Drug susceptibility testing of Mycobacterium tuberculosis: a neglected problem at the turn of the century. Int J Tuberc Lung Dis 1999; 3(7): 564-81.
12. Telenti A. Genetics of drug resistance in tuberculosis. Clin Chest Med 1997; 18(1): 55-64.
13. Tang SJ, Xiao HP. The research in fractional cultivation technology of mycobacterium. Chinese Journal of Tuberculosis and Respiratory Diseases 2000; 23(12): 762-4.
14. Garrigó M, Aragón LM, Alcaide F, Borrell S, Cardeñosa E, Galán JJ, et al Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol 2007; 45(6): 1766-70.
15. Brunello F, Fontana R. Reliability of the MB/BacT system for testing susceptibility of Mycobacterium tuberculosis complex isolates to antituberculous drugs. J Clin Microbiol 2000; 38(2): 872-3.
16. Adjers-Koskela K, Katila ML. Susceptibility testing with the manual mycobacteria growth indicator tube (MGIT) and the MGIT 960 system provides rapid and reliable verification of multidrug-resistant tuberculosis. J Clin Microbiol 2003; 41(3): 1235-9.
17. Bemer P, Palicova F, Rüsch-Gerdes S, Drugeon HB, Pfyffer GE. Multicenter evaluation of fully automated BACTEC Mycobacteria Growth Indicator Tube 960 system for susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol 2002; 40(1): 150-4.
18. Qing KQ, Qin J, Zhou XP. Functional assessment of drug sensitivity for BACTEC MGIT 960 in the detection of mycobacterium tuberculosis. Huaxin Medicine 2004; 19(2): 203-4.
19. Zhang YR, Wu XZ, Jing LJ, Chen HP. The comparision of two detection method for mycobacterium tuberculosis. The Journal of Clinical Lung 2003; 8(6): 561-2.
20. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003; 3(25): 1-13.
21. Zamora J, Muriel A, Abraira V: Meta-DiSc for Windows: A Software package for the Meta-analysis of Diagnostic Tests.
22. Walter SD. Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat Med 2002; 21(9): 1237-56.
23. Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 1993; 12(14): 1293-316.
24. Lijmer JG, Bossuyt PM, Heisterkamp SH. Exploring sources of heterogeneity in systematic reviews of diagnostic tests. Stat Med 2002; 21(11): 1525-37.
25. Deeks JJ. Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. BMJ 2001; 323(7305): 157-62.
26. Pai M, McCulloch M, Enanoria W, Colford JM Jr. Systematic reviews of diagnostic test evaluations: What's behind the scenes? ACP J Club 2004; 141(1): A11-3.